TRV GP IV’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,343,154
| Closed | -$8.37M | – | 3 |
|
|
2024
Q3 | $8.37M | Hold |
2,343,154
| – | – | 5.16% | 3 |
|
|
2024
Q2 | $14.5M | Hold |
2,343,154
| – | – | 7.18% | 3 |
|
|
2024
Q1 | $22.1M | Hold |
2,343,154
| – | – | 10.72% | 3 |
|
|
2023
Q4 | $15.8M | Hold |
2,343,154
| – | – | 6.43% | 3 |
|
|
2023
Q3 | $10.4M | Hold |
2,343,154
| – | – | 3.92% | 3 |
|
|
2023
Q2 | $7.73M | Hold |
2,343,154
| – | – | 6.99% | 3 |
|
|
2023
Q1 | $6.68M | Hold |
2,343,154
| – | – | 4.77% | 3 |
|
|
2022
Q4 | $17.1M | Hold |
2,343,154
| – | – | 7.25% | 4 |
|
|
2022
Q3 | $19M | Hold |
2,343,154
| – | – | 11.08% | 4 |
|
|
2022
Q2 | $11.5M | Hold |
2,343,154
| – | – | 7.55% | 4 |
|
|
2022
Q1 | $55.4M | Hold |
2,343,154
| – | – | 20.3% | 2 |
|
|
2021
Q4 | $41.5M | Hold |
2,343,154
| – | – | 11.92% | 2 |
|
|
2021
Q3 | $66.1M | Hold |
2,343,154
| – | – | 15% | 2 |
|
|
2021
Q2 | $24.6M | Hold |
2,343,154
| – | – | 11.69% | 4 |
|
|
2021
Q1 | $27.6M | Hold |
2,343,154
| – | – | 10.17% | 4 |
|
|
2020
Q4 | $27.4M | Hold |
2,343,154
| – | – | 8.8% | 5 |
|
|
2020
Q3 | $18.6M | Hold |
2,343,154
| – | – | 6.4% | 5 |
|
|
2020
Q2 | $42.9M | Hold |
2,343,154
| – | – | 19.74% | 4 |
|
|
2020
Q1 | $28M | Hold |
2,343,154
| – | – | 25.58% | 3 |
|
|
2019
Q4 | $39M | Hold |
2,343,154
| – | – | 24.31% | 2 |
|
|
2019
Q3 | $15.6M | Buy |
+2,343,154
| New | +$15.6M | 15.92% | 2 |
|